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Introduction
Platelets or thrombocytes are enucleated cell fragments derived from precursor megakaryocytes during megakaryopoiesis. Platelets play a key role in hemostasis and in the pathogenesis of atherothrombosis and cancer (Weber 2005; Willoughby et al. 2002; Cameron et al. 1983; del Zoppo 1998; McBane et al. 2004; Honn et al. 1992; Pain et al. 2001; Kottke-Marchant 2009 ). In addition, platelets are involved in several biological processes including immune and inflammatory response, vascular integrity, wound healing, and tumor metastasis (Kunicki and Nugent 2010; Kunicki et al. 2009; Smyth et al. 2009; Nachman and Rafii 2008; Gay and Felding-Habermann 2011a) .
The number of circulating platelets (PLT) in an individual is regulated by a balance between thrombopoiesis and platelet consumption and senescence (Daly 2011) . The mean platelet volume (MPV), a measure of platelet size, is determined at the time of platelet production from megakaryocytes and is inversely related to PLT. The precise molecular mechanisms regulating PLT and MPV are not well characterized. Platelet traits are heritable and in one study (Johnson 2011) , 84 % of the variance in PLT was attributed due to genetic factors. A high heritability of 75 % for MPV has also been reported (Kunicki and Nugent 2010; Mahaney et al. 2005; O'Donnell et al. 2001) .
To identify genetic variants associated with PLT and MPV, we performed a genome-wide association study (GWAS) in 13,582 patients of European ancestry in the electronic MEdical Records and GEnomic (eMERGE) network (http://www.gwas.net). As platelets and plateletderived growth factors are important mediators in inflammation, atherosclerosis, and neoplasia (Gay and FeldingHabermann 2011a, b; Gawaz et al. 2005; Huo and Ley 2004; Labelle et al. 2011) , we investigated whether genetic variants associated with PLT/MPV have pleiotropic effects on other disease phenotypes, using a phenome-wide association study (PheWAS) (Denny et al. 2010; Pendergrass et al. 2011) ( Figure S1 ). The PheWAS approach is uniquely possible in the eMERGE network given that the genotypes are linked to a wide range of phenotypes represented in the electronic medical record (EMR). Further, we inferred the functional categories, biological pathways, and diseases mediated by genes encoded in the loci associated with PLT and MPV using biological enrichment analyses.
Methods

Phenotyping
The complete blood count (CBC), typically measured by automated hematology analyzers, is a commonly performed test in the clinical setting. PLT values were available in the EMR for up to 13,582 patients with extant GWAS data from the five sites of the eMERGE (phase I) network (McCarty et al. 2011) as part of the CBC; MPV values were available for 46.3 % (n = 6,291) of the patients in the cohort. Samples with PLT values B100 or C600 (9109/L) were excluded. Of the remaining PLT and MPV lab values, the median value was extracted for each study participant and included in further analyses. Additionally, we excluded patients with hematological disorders including cancer, iron deficiency, and anemia using an EMR-based algorithm [available at the compendium of EMR-derived clinical phenotypes (PheKB; URL: http:// phekb.org/)]; The algorithm for PLT and MPV traits can be accessed at the URL:http://www.phekb.org/phenotype/ platelet-count-plt-and-mean-platelet-volume-mpv.
EMR-linked GWAS of PLT and MPV
We performed a GWAS for PLT in 13,582 patients of European ancestry identified from five sites in the eMERGE network (Table 1) ; and for MPV in 6,291 patients from Mayo Clinic, Marshfield Clinic, and Northwestern University. The study design ( Figure S1 ) and the distributions of PLT and MPV traits are depicted in the supplemental material ( Figure  S2 ). The clinical laboratories of Group Health and Vanderbilt did not report MPV as part of a CBC. As previously described (Kullo et al. 2010; Turner et al. 2011) , genotyping was performed in patients of European ancestry at the Center for Genotyping and Analysis at the Broad Institute (MAYO, VUMC, and NU) and the Center for Inherited Disease Research at the Johns Hopkins University (MC and GHC) using the Illumina Human660W-Quadv1_A genotyping platform, consisting of 561,490 SNPs and 95,876 intensityonly probes. Data were cleaned using the quality control (QC) pipeline developed by the eMERGE Genomics Working Group (Turner et al. 2011) . The process includes evaluation of sample and marker call rate, gender mismatch and anomalies, duplicate and HapMap concordance, batch effects, HardyWeinberg equilibrium, sample relatedness, and population stratification. A total of 476,395 SNPs were available for analysis after applying the following QC criteria: SNP call rate [98 %, sample call rate [98 %, minor allele frequency [0.05, Hardy-Weinberg equilibrium P value [0.001, and 99.99 % concordance rate in duplicates. The first two dimensions were derived from multidimensional decomposition analysis (using 'cmdscale' function in R) of the 1-IBS (identity-by-state) matrix based on all eMERGE samples (n = 17,358). Samples [6 standard error from the mean of self-reported white ethnicity on dimensions 1 and 2 were excluded. After QC steps, 13,582 patients (i.e., patients with genetically defined European ancestry) with phenotype and genotype data were available for association analyses.
Statistical analyses
When multiple measurements of platelet traits were available for an individual patient, we chose the median value and the corresponding age for the genetic analyses. We used an efficient mixed-model association expedited (EMMAX) algorithm (Ehret et al. 2011 ) to correct for sample relatedness and cryptic population substructure. The IBS matrix was calculated for each pair of individuals using the genome-wide genotype data. The generalized least squares F test was used to estimate the regression coefficient (b) and perform association analyses (Kang et al. 2010) , which were implemented in the R 'emmax' package, with adjustment for age, sex, and site. The statistical power of our study was 80 % to detect a quantitative trait locus that explained 0.29 % of variance in PLT and 0.63 % in MPV, given a sample size of 13,582 and 6,291, respectively, and a significance level of 5E-8. We imputed all non-genotyped SNPs in 20 autosomal chromosomes based on HapMap II CEU database (release 21). Imputation-based association for non-genotyped SNPs was performed using the same IBS matrix for the genotyped SNPs by EMMAX. Locuszoom (Pruim et al. 2010 ) was used for the visualization of genomic loci associated with platelet traits.
Imputation
A recent genome-wide meta-analyses of PLT (n = 48,000) and MPV (n = 23,000) in subjects of European ancestry found 85 SNPs in 69 regions on 20 autosomal chromosomes that were associated with PLT and MPV (Gieger et al. 2011) . Of the 56 SNPs associated with PLT, 23 were genotyped on the Illumina 660W platform used in the eMERGE network. We were able to impute the remaining 33 based on HapMap II CEU using the Markov Chainbased haplotyper (MACH) program (Li et al. 2010 ).
PheWAS of variants influencing PLT and MPV
We performed PheWAS on 81 SNPs achieving genomewide significant associations with PLT, MPV, or both, either in this study or in a prior GWAS of PLT and MPV (Gieger et al. 2011) . For this analysis, we combined the entire eMERGE cohort of European American individuals (n = 13,688) identified across the five eMERGE sites. To define diseases, we queried all International Classification of Disease (ICD), 9th edition, codes from the respective EMRs of the five eMERGE sites as previously described (Denny et al. 2011) . Briefly, for each disease, the PheWAS algorithm constructed case populations by grouping ICD codes into 1,368 related case groups (e.g., ''type 1 diabetes'', ''hypertension''). To be a case, an individual must have at least two ICD codes in that case group. A control population for each phenotype is constructed by selecting all patients that do not have the case disease or closely related diseases (e.g., a patient with a bundle branch block cannot serve as a control for complete heart block). Based on a single-SNP Bonferroni correction, a P value of 0.05/ 1,368 = 3.6E-5 was considered to be significant. The PheWAS methodology (Denny et al. 2010 ) has previously been validated through rediscovery of known associations (Denny et al. 2011 ). Analysis of each phenotype then proceeds using a pairwise analysis of all case and control groups for each tested SNP. As with other PheWAS, we did not analyze phenotypes that occurred in less than 25 patients (a prevalence of 0.18 % in the dataset). The Phe-WAS was performed with PLINK using logistic regression analyses that adjusted for age and gender and assumed an additive genetic model (Purcell et al. 2007 ).
Functional enrichment analysis of genes harboring variants regulating PLT/MPV
Genome-wide association study analysis implicated multiple genetic variants as modulators of platelet traits. To understand the functional similarity and diversity of these genes, we used a bioinformatics analysis pipeline (See Supplementary material; Figure S2 ) that combined three different tools: Protein ANalysis Through Evolutionary Relationship (PANTHER) (Thomas et al. 2003 ) was used to perform Gene Ontology term and protein class enrichment analysis. These analyses were used to understand the functional similarity of genes associated with PLT and MPV. GO term enrichment analyses were used to find significant (binomial statistics; P \ 0.05) terms under the categories of biological processes, molecular functions, and cellular compartments. Protein class enrichment analyses were performed (binomial statistics; P \ 0.05) to find evolutionarily conserved globular domains encoded in genes influencing platelet traits. Reactome pathway annotations (Matthews et al. 2009 ) were used to identify major molecular events mediated by the genes. Significance was defined using a hypergeometric test (P \ 0.05). Functional annotation based on Gene Ontology or molecular event annotations does not capture known gene-disease associations. To identify the disease-associated genes influencing PLT and MPV, we performed an enrichment analysis using Disease Ontology. Disease Ontology enrichment analysis was performed using Functional Disease Ontology server using a simplified version of Disease Ontology (DO-Lite) (Du et al. 2009 ) to identify enrichment of diseases reported to be associated with genes influencing PLT and MPV (hypergeometric test; P \ 0.05). Expression levels of genes harboring the variants that regulate PLT and MPV in megakaryocyte (n = 4) were examined using HaemAtlas ). indicates the genome-wide significance level of P = 5E-8. In the quantile-quantile (QQ) plot, the horizontal axis shows (-log10 transformed) expected P values, and the vertical axis indicates (-log10 transformed) observed P values
Results
There were 13,424 patients of European ancestry with PLT data; 6,291 of these patients also had MPV data from five eMERGE sites after exclusion of patients (n = 158) with abnormal PLT or MPV values. Sample characteristics are shown in Table 1 ; distributions of platelet traits across the eMERGE sites are provided in Figure S2 . The two traits were negatively correlated (gender-adjusted r = -0.36) with each other. We identified five chromosomal regions associated with PLT ( Fig. 1a) , eight regions associated with MPV ( Fig. 1b ) (P \ 5E-8) ( Table 2 ) and 1 region (3p14.3) associated with both traits.
Regions associated with PLT Chromosome 3p14.3. An intronic SNP (rs1354034) in the Rho guanine nucleotide exchange factor 3 gene (ARHGEF3) was associated with PLT (b = 7.97, P = 6E-24). Rho-like GTPases are involved in a variety of cellular processes, activated by binding GTP, and inactivated by conversion of GTP to GDP by their intrinsic GTPase activity. Chromosome 12q24.12. A missense SNP (rs3184504) in SH2B3 was associated with PLT (b = -5.33, P = 5E-12). This SNP has been associated with multiple phenotypes, including type 1 diabetes (Hunt et al. 2008; Todd et al. 2007 ), blood pressure (Levy et al. 2009 ), eosinophil count, and myocardial infarction (Gudbjartsson et al. 2009 ). Another SNP (rs739496, r 2 = 0.23 with rs3184504) at this locus was associated with PLT in a Japanese cohort (Kamatani et al. 2010) . Soranzo et al. (2009a) found an adjacent SNP (rs11065987) in ATXN2 to be associated with PLT. We also found a SNP rs653178 in ATXN2 to be associated with PLT; however, this SNP is in LD with the missense SNP rs3184504 (r 2 = 1) in SH2B3. The pleiotropic associations of rs3184504 reported in prior studies along with findings from PLT/MPV GWAS-PheWAS analyses are summarized in Table S8 .
Chromosome 11p15.5. Several SNPs near the telomere region of chromosome 11p were associated with PLT (the most significant SNP was rs11602954, b = -6.46, P = 5E-12). Six genes reside in this region: SCGB1C1, ODF3, RIC8A, BET1L, SIRT3, and PSMD13. The SNP rs11602954 may regulate expression of the neighboring genes BET1L and SIRT3 as well as PSMD13 to a lesser degree (Soranzo et al. 2009a ).
Chromosome 6q23.3. An intergenic SNP (rs4895441) between HBS1L and MYB genes was associated with PLT (b = -5.24, P = 9 9 10E-10). Another intergenic SNP (rs9399137, P = 1 9 10 -9 ) within this region was also associated with PLT (Ferreira et al. 2009 ). We have previously found this locus to be also associated with red blood cell (RBC) traits: RBC count, mean corpuscular volume, mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin (MCHC) (Kullo et al. 2010) . Chromosome 9p24.1. A SNP in the 5 0 flanking region of RCL1 was associated with PLT (b = -4.94, P = 1E-9). The locus was noted to be to be associated with PLT (rs385893, P = 9E-17) in a previous study (Soranzo et al. 2009a) . Regional plots of five chromosomal regions influencing PLT are provided in Fig. 2 .
Regions associated with MPV Chromosome 3p14.3. An intronic SNP (rs1354034) in ARHGEF3 was associated with MPV (b = -0.19, P = 9E-34). SNPs in ARHGEF3 have been reported to be associated with MPV in previous studies (Soranzo et al. 2009a; Meisinger et al. 2009 ).
Chromosome 7q22.3. Several SNPs on chromosome 7q22.3 were associated with MPV (most significant SNP rs342240, b = -0.15, P = 5E-22). These SNPs are located in the intergenic region of FLJ36031 and PIK3CG. Soranzo et al. (2009a) found this locus to be associated with MPV (P = 1E-24). RNA expression analysis of this region showed a significant association with PIK3CG expression and platelet levels (Soranzo et al. 2009b ). This locus contains multiple transcription factor-binding sites that regulate the expression level of PIK3CG and rs342240 disrupts an in silico predicted transcription factor-binding site in the intergenic region (Paul et al. 2011) .
Chromosome 1q32.1. Multiple SNPs in LD on chromosome 1q32.1 were associated with MPV (most significant SNP rs9660992, b = 0.11, P = 3E-13). This region contains several genes including CNTN2, TMEM81, DSTYK, TMCC2, and NUAK2. The SNP rs9660992 is located in the 3 0 untranslated region of TMCC2. Another intronic SNP in TMCC2 (rs1668873, r 2 = 0.62 with rs9660992) has been reported to be associated with MPV (Soranzo et al. 2009a) .
Chromosome 1q24.3. Intronic SNPs in DNM3 were associated with MPV (the most significant SNP was rs2180748, b = 0.09, P = 2E-8). An intronic SNP rs10914144 in DNM3 (P = 2E-14), which is in moderate LD (r 2 = 0.31) with rs2180748, was associated with MPV in a previous study (Soranzo et al. 2009a) .
Chromosome 10q21.2. Multiple SNPs in LD, spanning a region of *400 kb on chromosome 10q21.2 (lead SNP: rs4379723 P = 3E-16) were associated with MPV. Five genes reside in this region, including NRBF2, JMJD1C, MIR1296, LOC84989, and REEP3. This region has been previously reported to be associated with MPV (Soranzo et al. 2009a) .
Chromosome 17q11.2. Three intronic SNPs in TAOK1 and one SNP in the 3 0 regulatory region of TAOK1 on chromosome 17q11.2 were associated with MPV (the most significant SNP was rs9900280, b = 0.1, P = 1E-10). This locus has been reported to be associated with MPV in previous studies (Soranzo et al. 2009a; Meisinger et al. 2009 ).
Chromosome 12q13.13. Two SNPs in LD on chromosome 12q13.13 were associated with MPV. The most significant SNP (rs10506328, b = -0.09, P = 2E-9) is in an intron of NFE2. The same SNP was reported to be associated with MPV (P = 5E-7) in a previous study (Soranzo et al. 2009a ).
Chromosome 12q24.1. Multiple SNPs on chromosome 12q24.1 were associated with MPV. The most significant SNP rs7961894 (b = -4.94, P = 1E-9) is located in an intron of WDR66. Variants in WDR66 have been reported to be associated with MPV (Meisinger et al. 2009; Soranzo et al. 2009b ). The LD between rs7961894 and other significant SNPs was weak (r 2 \ 0.3) and it is possible that multiple independent genes contribute to variation in MPV including TMEM120B, SETD1B, PSMD9, and BCL7A. Regional plots of eight chromosomal regions influencing PLT are provided in Fig. 3 .
Replication of previously reported genetic regions associated with PLT/MPV
Using an alpha of 9E-04 to correct for multiple testing, 9 of the 23 genotyped and 11 of the 33 imputed SNPs were replicated (Table S1 ). Of 29 SNPs associated with MPV, 5 were genotyped in the present study and 24 were imputed. A total of 22 SNP associations with MPV were replicated (Table S2) . Genes in these regions influence thrombopoiesis and encode kinases (AK3, DSTYK, PIK3CG, TAOK1), membrane proteins (BET1L, COPZ1, REEP3, TMCC2, TMEM81, TMEM120B), proteins involved in cellular trafficking (DNM3, NRBF2, REEP3), transcription factors (JMJD1C, MYB, NFE2, NRBF2, RBBP5), proteasome complex subunits (PSMD13), proteins of signal transduction pathways (ARHGEF3, SH2B3), proteins involved in megakaryocyte development and platelet production (AK3, CABLES1, EHD3, JMJD1C, MYB, NFE2, SH2B3), and hemostasis (SH2B3, JMJD1C, MYB, EHD3, PIK3CG, F2R, SIRPA, PTPN11, CABLES1, AK3, THPO, NFE2).
A recent meta-analysis of GWAS in African Americans (Qayyum et al. 2012 ) revealed 11 regions to be associated with PLT and MPV. We replicated five loci associated with PLT (6q23, 7q22, 10q21, 12q24) and 2 loci (7q22 and 17q11) associated with MPV, in the European ancestry patients in our cohort.
PheWAS of variants associated with PLT and MPV
We analyzed a total of 81 SNPs using PheWAS: 56 for PLT, 29 for MPV (4 SNPs were associated with both phenotypes). Phenotypic associations are summarized in Table 3 . Figure 4 shows the PheWAS plots for SNPs associated with PLT and MPV. Multiple autoimmune and hematological conditions were associated with these SNPs. The strongest associations were of ankylosing spondylitis (P = 3.3E-7), inflammatory spondylopathies (P = 5.7E-8), and uveitis (P = 4.6E-7) with rs381299 in HLA-B. Associations between HLA-B and ankylosing spondylitis have been reported previously (Evans et al. 2011 ). Additional associations included that of psoriasis and psoriatic arthropathy with rs6065 in GP1BA, dermatomyositis/ Fig. 2 Regional plots of five loci associated with platelet count (PLT) on chromosomal regions: 3p14.3, 6q23.3, 9p24.1, 11p15.5, and 12q24.12. Single-nucleotide polymorphisms (SNPs) are plotted by position on the chromosome (x-axis) and the association with PLT (-log 10 P value) on the y-axis. The rs number for the most significant SNP in the joint analysis is shown on the plot. Estimated recombination rates (from HapMap) are plotted in cyan to reflect the local linkage disequilibrium (LD) structure. The SNPs near the most significant SNP are color coded to depict their LD with the lead SNP (derived using pairwise r 2 values from the HapMap CEU data). Genes, the position of exons, and the direction of transcription from the University of California, Santa Cruz genome browser are also plotted. polymyositis with rs7149242 at 14q32.2 near C14orf70/ DLK1, and hypothyroidism (which is typically an autoimmune disease) with missense variant rs3184504 in SH2B3, all at P \ 2E-4. A borderline significant association was noted for myocardial infarction and this missense variant in SH2B3 (P = 1.7E-04). Several GWAS have noted the association between this missense variant (rs3184504) with several complex traits and disease phenotypes including hypothyroidism (Eriksson et al. 2012 ) and myocardial infarction (Gudbjartsson et al. 2009) (Table S8 ). The mutation results in substitution of a nonpolar and neutral residue with a polar and positive residue on the pleckstrin homology (PH) domain of SH2B3 leading to an additional positively charged residue to the region that may influence the binding of SH2B3 with other protein partners involved in blood coagulation, hemostasis, or platelet activation pathways. Additional associations near statistical significance (all P \ 1.2E-04) noted in PheWAS were those of several hematological conditions: B12-deficiency anemia with rs9399137 at 6q23.3 near HBS1L-MYB, thrombocytopenia with rs2950390 at 12q13.3 near PTGES3-BAZ2A, leukemia with rs6995402 in plectin gene (PLEC), and aplastic anemia with rs7961894 in WD repeat-containing protein 66 (WDR66).
Biological enrichment analysis of genes influencing PLT and MPV
We investigated functional associations of genes influencing PLT and MPV. Detailed descriptions of the methods ( Figure S3 ) are provided in the Supplementary Material. Briefly, biological enrichment analysis was performed using a merged list of genes from the significant loci identified from GWAS and imputation analysis. We identified significantly enriched GO annotations using enrichment analysis. GO term analyses (Table S3 ) revealed seven terms under 'biological processes' category that were associated with PLT and MPV; out of these five terms were significant for both traits. Six terms under 'molecular function' category were associated with PLT and five terms were associated with MPV with one term ''lyase activity'' associated with genes influencing both traits. Protein classes (Table S4 ) associated with the genes were ascertained using protein class enrichment analysis using protein relationships compiled in PANTHER Ontology. Protein classes ''membrane traffic protein'' and ''vesicle coat protein'' were associated with genes influencing both PLT and MPV. Molecular events (individual cellular events derived from biological processes delineated as molecular interactions facilitated by enzymes or other molecular catalysts) associated with genes were derived using Reactome annotations (Table S5) . Two molecular events ''Factors involved in megakaryocyte development and platelet production'' and ''Hemostasis'' were associated with both traits. Disease Ontology terms ( Figure S4 and Table S6 ) associated with genes influencing PLT and MPV were derived. Five Disease Ontology terms including ''myeloproliferative disease'', ''leukemia'', and ''autoimmune disease'' were identified as significant in disease term enrichment analysis. GO term enrichment analysis did not reveal any significant cellular compartment terms. Functional in vitro studies of variants identified by GWAS have shown that specific genetic variants have critical role in cell-types (Raychaudhuri 2011; Blattmann et al. 2013; Trynka et al. 2013 ). To understand cell-type specific expression profile of platelet trait-associated genes, we leveraged publicly available expression data. Expression levels of genes influencing PLT and MPV in megakaryocytes (precursor of platelets in hematopoietic cell lineage) were obtained from HaemAtlas database; we noted several genes had high level of expression in megakaryocytes (See Table S7 and Figure S3 ). We also performed a comparative analysis of genes implicated in platelet function, PLT and MPV and noted SNPs in JMJD1C to be associated with all three traits (See Supplementary Material; Figure S5 ).
Discussion
In the present study, we performed an EMR-based GWAS of PLT and MPV in 13,582 patients of European ancestry from five sites of the eMERGE network and examined the pleiotropic effects of these variants using a PheWAS approach. We identified five chromosome regions associated with PLT and eight associated with MPV, respectively. We replicated 20 SNPs influencing PLT [out of 56 SNPs (a: 0.05/56 = 9E-04)] and 22 SNPs [out of 29 SNPs (a: 0.05/29 = 2E-03)] influencing MPV from among 69 SNPs discovered in a recent meta-analysis of PLT and MPV (Gieger et al. 2011) . Our study illustrates the potential use of EMR-based genomic studies to identify novel genetic loci for medically important quantitative traits, as well as to replicate prior associations and identification of potential genotype-phenotype association using the PheWAS approach. PheWAS using a single-SNP Bonferroni correction (0.05/1,368 = 3.6E-5) revealed that several variants influencing PLT and MPV have pleiotropic effects and are associated with diverse phenotypes including myocardial infarction, autoimmune and hematologic diseases, highlighting pleiotropic effects of these variants. Additionally, several variants were associated at near-significance with hematologic conditions that may, in part, explain their association with PLT and/or MPV.
A missense variant (rs3184504) in SH2B3, associated with PLT, was also associated with hypothyroidism and myocardial infarction in our PheWAS. This variant has been previously noted to be associated with cardiovascular diseases including myocardial infarction and coronary artery disease (Ripatti et al. 2010; Saade et al. 2011) , Type 1 diabetes (Hinks et al. 2010) , autoimmune disorders (multiple sclerosis, systemic lupus erythematous, Graves disease, juvenile rheumatoid arthritis, Addison disease, and celiac disease) (Alcina et al. 2010; Hunt et al. 2008) , asthma (Gudbjartsson et al. 2009 ), hypothyroidism (Eriksson et al. 2012 , and hypertension (Newton-Cheh et al. 2009 ) (See Table S8 for a summary of the diverse phenotypes associated with rs3184504). SH2B3 encodes a multi-domain protein with two highly conserved functional domains [PH domain and Src homology 2 (SH2) domain] and is involved in blood coagulation and erythropoietin (EPO) signaling pathway (Tong et al. 2005) . The variant rs3184504 influencing PLT is a missense mutation in SH2B3 resulting in a residue change from tryptophan (aromatic side chain) to arginine (large size and basic side chain) substitution. This variant is present in a conserved PH domain involved in lipid binding (Wang and Shaw 1995) .
Phenome-wide association study analysis replicated the known association between rs3819299 (an intronic variant of HLA-B associated with PLT) and ankylosing spondylitis. Indeed, MPV has been used as a marker of disease activity in ankylosing spondylitis and rheumatoid arthritis (Kisacik et al. 2008) . Several of the Phe-WAS findings are novel, representing rare conditions not yet studied in GWAS (e.g., dermatomyositis and chronic glomerulonephritis). The association of aplastic anemia with rs7961894 in WDR66 suggests that the changes in PLT and MPV associated with these SNPs represent a continuum between variation of normal and conditions resulting in disease manifestation. Finally, another class of associations present may represent regulation of platelet count or function: menstrual irregularities, gastrointestinal complications, and complications of trauma. We also noted that several previously reported genotype-disease associations identified using GWAS were not captured in our PheWAS analysis. Additional studies are needed to validate these associations including studies in model organisms, epigenomic assays, and targeted ex vivo or in vitro assays (Schaub et al. 2012) .
The catalog of GWAS-identified genetic variations and their phenomic associations is expanding (Denny et al. 2011; Ritchie et al. 2013; Hebbring et al. 2013) . Our PheWAS results highlighted novel phenome associations of platelet-related genetic variants such as dermatomyositis and polymyositis and chronic glomerulonephritis. While the PheWAS approach (Denny et al. 2010 ) has been validated through rediscovery of known associations, akin to any genetic or phenomic studies, replication and functional validation of the associations will be needed, particularly since our threshold for statistical significance in these analyses may be considered liberal.
Statistical enrichment analyses were performed to understand functional repertoire, biological pathways, and diseases mediated by genes regulating PLT and MPV. Functional enrichment analysis revealed that the genes influencing PLT and MPV traits included kinases, membrane proteins, transporter proteins including proteins involved in cellular trafficking, proteasome complex subunit, transcription factors as well as genes implicated in signal transduction pathways relevant to megakaryocyte development and platelet production. The platelet life cycle involves a series of complex biological processes and molecular functions. Variants influencing PLT and MPV are distributed in several genes that influence multiple cellular mechanisms such as trafficking, cell signaling pathways, membrane dynamics, and generation of precursor cells of platelets (megakaryocytes). Previous investigations have revealed cellular trafficking mechanisms to be associated with platelet lifecycle including endocytosis/ pinocytosis by megakaryocytes, phagocytosis of platelets by macrophages in the spleen, and secretion of platelet granules by exocytosis to mediate hemostasis (Smyth et al. 2009; Nachman and Rafii 2008; Gieger et al. 2011; Movat et al. 1965; Kaplan and Saba 1978; Italiano et al. 1999; Denzer et al. 2000; Flaumenhaft 2003; Reed 2004; Patel et al. 2005; Richardson et al. 2005; Suehiro et al. 2005; Blair and Flaumenhaft 2009; Thon et al. 2010 ). Signaling pathways have also shown to be pivotal for normal platelet function; platelet activation, aggregation, and adhesion are mediated by signal transduction events facilitated by signaling molecules and platelet receptors (Fitzgerald 1999; Dhar and Shukla 1993; Gibbins 2004) . Signal transduction pathways via phosphorylation events also influence platelet lifecycle (Levy-Toledano 1999; Li et al. 2010) . The ubiquitin-and proteasome-dependent proteolytic pathway degrades the majority of cellular proteins and previous studies indicate a role of proteolysis in megakaryocytes and platelet function (Schulze et al. 2004; Qiao et al. 2010 ).
Several genes involved in aforementioned molecular pathways were found to be harboring variants influencing PLT and MPV (Table S3 , S4, and S5). For example, three protein kinases: adenylate kinase 3 (AK3), phosphoinositide-3-kinase catalytic subunit gamma isoform (PIK3CG), and TAO kinase 1 gene (TAOK1) encoding a microtubule affinityregulating kinase that regulates mitotic progression and autophagy (Behrends et al. 2010) , were associated with platelet traits (Table S4) . Protein kinases play a significant role in signal transduction via phosphorylation (Levy-Toledano 1999; Li et al. 2010) . Signal transduction and kinase related terms were significantly enriched among the genes influencing the two platelet traits (Tables S3 and S4 ; all P \ 0.05). Transcription factors such as nuclear factor (erythroid-derived 2) (NFE2) play an important role in platelet biogenesis. NFE2 overexpression is associated with enhanced megakaryocyte differentiation, proplatelet development, and platelet release while loss of NFE2 function results in lethal embryonic thrombopoietic defects and severe thrombocytopenia (Soranzo et al. 2009a, b) . We also replicated multiple intergenic SNPs associated with PLT [HBS1L-MYB (Wahlberg et al. 2009; Menzel et al. 2007 ), RPH3A-PTPN11 (Gieger et al. 2011) ] and MPV [FLJ36031-PIK3CG (Paul et al. 2011 ), CD9-VWF (Gieger et al. 2011) ] suggesting transcriptional regulation of platelet phenotypes. Further, we observed that transcription factor-related terms [translation elongation factor activity (P = 8.11E-03), transcription cofactor activity (P = 8.11E-03)] enriched among the genes that harbor variants influencing platelet traits. Genes and related key functional pathways derived from functional annotation analyses are summarized in the context of platelet biogenesis in Fig. 5 .
Summary
Our study highlights the way in which high-throughput EMR-based genomic and phenomic studies can be integrated to identify genetic variants influencing clinically relevant traits and their pleiotropic effects. We identified five chromosomal regions associated with PLT, eight regions associated with MPV, and one region associated with both traits. PheWAS analyses revealed that several SNPs influencing platelet traits are associated with diverse phenotypes including myocardial infarction, autoimmune diseases, and hematologic disorders. Our functional annotation approach including GO annotations, protein class annotations, and molecular event annotations, highlights the diverse biological functions played by various gene families associated with platelet traits. Our results provide a framework to understand the role of biological pathways regulating platelet traits and the pleiotropic effects of genes influencing these traits.
